Brief: Kane Biotech Engages Research Capital To Conduct Strategic Review Of Stem Animal Health

Kane Biotech

02/08/2023 13:31

Aug 2 (Reuters) - Kane Biotech Inc  KNE.V :
    * KANE BIOTECH ENGAGES RESEARCH CAPITAL TO CONDUCT STRATEGIC
REVIEW OF STEM ANIMAL HEALTH
    * KANE BIOTECH INC - KANE IS CONSIDERING A VARIETY OF
STRATEGIC
ALTERNATIVES
    * KANE BIOTECH INC - ALTERNATIVES COULD INCLUDE, SALE OF ALL
OR
PART OF ITS ASSETS IN STEM
    * KANE BIOTECH INC - ALTERNATIVES COULD INCLUDE A MERGER OR
OTHER
BUSINESS COMBINATIONS WITH ANOTHER PARTY, OR ANY OTHER STRATEGIC
TRANSACTION

Source text for Eikon:  ID:nGNX3WDlfV 
Further company coverage:  KNE.V 

 ((Reuters.Briefs@thomsonreuters.com;))